The group's nine-month overall revenue grew to 583 million euros compared to last year's results of 846 million euros, driven ...

The company reported on Tuesday that its revenues jumped 8 percent in North America and Europe during the third quarter but fell slightly in the rest of the world.

Equities research analysts at StockNews.com started coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Get Free Report) in a research report issued on Wednesday. The firm set a “sell” ...

The global veterinary reference laboratory market is forecast to grow at a compound annual growth rate (CAGR) of more than 9% during the forecast period from 2022-2030. Request To Download Sample of ...